Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies

A major challenge in anticancer treatment is the pre-existence or emergence of resistance to therapy. AXL and MER are two members of the TAM (TYRO3-AXL-MER) family of receptor tyrosine kinases, which, when activated, can regulate tumor cell survival, proliferation, migration and invasion, angiogenes...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoumacher, Marie, Burbridge, Mike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Evolving Therapies (R Bukowski, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332501/
https://www.ncbi.nlm.nih.gov/pubmed/28251492
http://dx.doi.org/10.1007/s11912-017-0579-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332501/
https://www.ncbi.nlm.nih.gov/pubmed/28251492
http://dx.doi.org/10.1007/s11912-017-0579-4

Ejemplares similares